Spectrum gets FDA plant approval; Hovione and Solvias pair up on co-crystals; Public Citizen wants compounders inspected;

> Spectrum Pharmaceuticals' new manufacturing site has received FDA approval for the production of Fusilev injection for use in advanced metastatic colorectal cancer patients. Item

> Hovione has buddied up with Solvias to combine formulation capabilities and crystal design for manufacturing pharmaceutical co-crystals. Release

> The USP will delay new elemental impurities standards to get them synced up with those in ICH Q3D. Item

> Watchdog group Public Citizen has requested that the FDA reinspect more than a dozen specialty pharmacies with prior records of violations in light of the lethal meningitis outbreak tied to drugs manufactured by New England Compounding Center. Story

And Finally... Johnson & Johnson ($JNJ) says it is making its HIV drug Prezista available to generics makers in Africa and developing countries. Story

Suggested Articles

The FDA has lambasted the Torrent Pharmaceuticals in a warning letter for making OTC meds using water tainted with bacteria.

Eli Lilly is investing $400 million in its Indianapolis site to expand production of insulin and other diabetes meds, and add 100 jobs.

Recipharm has been building its capabilities in sterile injectable and inhalation drugs. Now it is buying a CDMO that manufactures devices for both.